These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28338261)

  • 1. Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.
    Lewis DJ; Duvic M
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28338261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
    Stevens SR; Baron ED; Masten S; Cooper KD
    Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the use of extracorporeal photopheresis for mycosis fungoides.
    Agi C; Kuhn D; Chung J; Zampella J; Hinds G
    J Dermatolog Treat; 2015 Jun; 26(3):266-8. PubMed ID: 25034002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
    Akilov OE
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis and multimodality therapy in patients with T-cell cutaneous lymphomas: Real-life experience in Argentina.
    Baquero Rey JA; Zambrano Franco EA; Andrade Miranda A; Marciano S; Mazzuoccolo LD; Enz PA
    J Clin Apher; 2021 Dec; 36(6):815-822. PubMed ID: 34478581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
    Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.
    Atzmony L; Amitay-Laish I; Gurion R; Shahal-Zimra Y; Hodak E
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2382-9. PubMed ID: 26299651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome.
    Sanli H; Akay BN; Anadolu R; Ozcan M; Saral S; Akyol A
    J Drugs Dermatol; 2011 Apr; 10(4):403-8. PubMed ID: 21455551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P; Fierro MT; Rossotto GL; Savoia P; Bernengo MG
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019.
    Girardi M; Carlson K; Huang X; Corman SL; Edmundson P; Schmier J; Kale HP; Raina R; Foss F
    J Dermatolog Treat; 2024 Dec; 35(1):2360568. PubMed ID: 38852942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
    Aires D; Abhyankar S
    Hematol Oncol; 2023 Dec; 41(5):809-816. PubMed ID: 37974524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elutriate isolation of Sézary cells in extracorporeal photopheresis.
    Gabbard AP; Booth GS
    J Clin Apher; 2020 Sep; 35(5):477-478. PubMed ID: 32809221
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicenter photopheresis intervention trial in early-stage mycosis fungoides.
    Talpur R; Demierre MF; Geskin L; Baron E; Pugliese S; Eubank K; Zic JA; Miller DR; Tharp M; Bohjanen K; Duvic M
    Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):219-27. PubMed ID: 21575927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I treat mycosis fungoides and Sézary syndrome.
    Whittaker S; Hoppe R; Prince HM
    Blood; 2016 Jun; 127(25):3142-53. PubMed ID: 27151889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal Photopheresis in Dermatological Diseases.
    Terhaar H; Saleem M; Yusuf N
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of cutaneous T-cell lymphoma with photopheresis.
    Zic JA
    Dermatol Ther; 2003; 16(4):337-46. PubMed ID: 14686977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
    Gettler SL; Fung MA
    Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.